Thorax

Article	Citations
Improving uptake of lung cancer screening: an observational study on the impact of timed appointments and reminders	215
Highlights from this issue	175
Journal club	158
Cardiovascular outcomes in obstructive sleep apnoea and implications of clinical phenotyping on effect of CPAP treatment	143
Assessing causal relationships between diabetes mellitus and idiopathic pulmonary fibrosis: a Mendelian randomisation study	116
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD	110
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension	98
The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study	98
Journal club	85
Highlights from this issue	77
Journal club	66
Circulating cell-free double-stranded DNA and metabolic derangements in idiopathic pulmonary fibrosis: a new association	64
COP27 climate change conference: urgent action needed for Africa and the world	59
Journal club	58
Journal club	56
Journal club	55
Time to treat the climate and nature crisis as one indivisible global health emergency	54
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol	54
Journal club	54
Genesis of concurrent diseases: do diabetes mellitus and idiopathic pulmonary fibrosis have a direct relationship?	53
Empyema necessitans secondary to bronchial stenting	53
Aerosol emission from the respiratory tract: an analysis of aerosol generation from oxygen delivery systems	51
Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study	51
Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial	50
Software using artificial intelligence for nodule and cancer detection in CT lung cancer screening: systematic review of test accuracy studies	48

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease	44
Multiple intrathoracic extramedullary haematopoiesis as visualised on medical thoracoscopy	43
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	42
Relationship between cumulative silica exposure and silicosis: a systematic review and dose-response meta-analysis	40
Collagen neoepitopes in sarcoidosis: what do they tell us?	40
Predictive value of lung function measures for cardiovascular risk: a large prospective cohort study	39
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD	39
Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?	38
Readmission following hospital admission for community-acquired pneumonia in England	36
Effects of non-invasive ventilation on sleep in chronic hypercapnic respiratory failure	36
Laryngeal widening and adequate ventilation by expiratory pressure load training improve aerobic capacity in COPD: a randomised controlled trial	35
Donor lung allocation scheme: how can we measure success?	35
Nasal versus oronasal masks for home non-invasive ventilation in patients with chronic hypercapnia: a systematic review and individual participant data meta-analysis	35
Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help?	35
Advanced MicroRNA delivery for lung inflammatory therapy: surfactant protein A controls cellular internalisation and degradation of extracellular vesicles	34
Environmental exposures associated with early childhood recurrent wheezing in the mother and child in the environment birth cohort: a time-to-event study	34
Shift work is associated with positive COVID-19 status in hospitalised patients	34
Apples to apples? Comparative analyses of national CF registries	33
Children’s charter for lung health	33
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review	33
Corticosteroid therapy for treating acute exacerbation of interstitial lung diseases: a systematic review	33
Refractory granulomatous Pneumocystis jirovecii pneumonia masquerading as malignancy	33
To progress or not to progress: new insights into the evolution of pleuropulmonary blastomas come from studying lung cysts in adolescents and adults withDICER1-related tumour predisposition	33
Lung allocation: a vexed, complex multifaceted challenge	33
Ablation for lung cancer: hot or cold intervention	33
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland	32
Height and bone mineral content after inhaled corticosteroid use in the first 6 years of life	32
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules	32
Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma	31
Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment	31
Tobacco use: a smoking gun for IPF?	31
Sleep-disordered breathing and ventilatory chemosensitivity in first ischaemic stroke patients: a prospective cohort study	31
COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usage	31
Massive thymoma mimicking a pleural mass	30
Clinical implications of airway obstruction with normal or low FEV1in childhood and adolescence	30
E-cigarette use in young adults and adolescents: not so safe?	30
Twenty-year-old patient with polyarthritis since childhood showing cysts and ground glass attenuation on HRCT	30
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	29
Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD	29
Physical activity and body mass related to catch-up lung function growth in childhood: a population-based accelerated cohort study	29
New path for understanding mucociliary clearance	29
ICU mobility and improved outcomes: still searching for the Holy Grail	28
Vectura and Philip Morris: the leopard has not changed its spots	27
Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study	27
Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?	27
Subtyping emphysematous COPD by respiratory volume change distributions on CT	27
Combining clinical, radiological and genetic approaches to pneumothorax management	27
Vaping and CBD: can new technology overcome old problems?	26
In vivo bronchial epithelial interferon responses are augmented in asthma on day 4 following experimental rhinovirus infection	26
ATP binding cassette member A3 (ABCA3): coming of age	26

Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	26
Admixture mapping of severe asthma exacerbations in Hispanic/Latino children and youth	25
Blowing hot and cold over asthma hospitalisations	25
Acute haemoptysis, fever and abdominal pain in an adolescent from northern Australia	25
High-flow nasal oxygen: benefits are hard to show in COVID-19 patients with mild hypoxaemia	25
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans	25
COVID-19 vaccine-related interstitial lung disease: a case study	24
Rapidly progressive interstitial lung disease complicated by pulmonary interstitial emphysema in anti-MDA5 amyotrophic dermatomyositis	24
Beware, vaping e-cigarettes around children is adversely impacting their lung health	24
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	24
Can we design better ARDS trials?	24
Journal club	24
Journal club	23
Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis	23
Correction: Association of asthma severity and educational attainment at age 6–7 years in a birth cohort: population-based record-linkage study	23
Correction:British Thoracic Society Winter Meeting 2023	23
Evolutive diaphragmatic lesions causing recurrent catamenial pneumothorax	23
Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease	22
Long-term effect of asthma on the development of obesity among adults: an international cohort study, ECRHS	22
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	22
Correction: British Thoracic Society Winter Meeting February 2021	22
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	21
Reversible bronchiectasis	21
Epidemiology of childhood interstitial lung disease in France: the RespiRare cohort	21
When is an AVM not an AVM?	21
Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis	21
Angiosarcoma of the pulmonary artery as an unexpected evolution of an apparent pulmonary thromboembolism	21
Complex coexistence of COPD and cardiovascular disease	21
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	20
Role of inflammasomes in acute respiratory distress syndrome	20
Ambient heat exposure and COPD hospitalisations in England: a nationwide case-crossover study during 2007–2018	20
A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL)	20
Secondhand nicotine vaping at home and respiratory symptoms in young adults	19
Lung epithelial cells interact with immune cells and bacteria to shape the microenvironment in tuberculosis	19
British Thoracic Society Clinical Statement on chronic cough in adults	19
Effects of tobacco smoking on recurrent hospitalisation with pneumonia: a population-based cohort study	19
Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort	19
Pulmonary telerehabilitation vs. conventional pulmonary rehabilitation – a secondary responder analysis	18
Inhaled corticosteroids may be useful in bronchiectasis with peripheral blood eosinophilia	18
Occlusive primary endobronchial amyloid tumour: a rare case	18
Improved childhood asthma control after exposure reduction interventions for desert dust and anthropogenic air pollution: the MEDEA randomised controlled trial	18
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)	18
Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection	18
Super-responders to anti-IL-5/anti-IL-5R are characterised by high sputum eosinophil counts at baseline	18
Bacterial biofilms predominate in both acute and chronic human lung infections	18
Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study	17
Inhaled pirfenidone solution (AP01) for IPF: a randomised, open-label, dose–response trial	17
Automatic oxygen titration versus constant oxygen flow rates during walking in COPD: a randomised controlled, double-blind, crossover trial	17
Use of inhaled corticosteroids and the risk of hospitalisation for pneumonia in children with asthma: a nationwide cohort study	17
Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis	17
Influence of age on clinical characteristics, pharmacological management and exacerbations in children with asthma	17
Unlocking the secrets of long non-coding RNAs in asthma	16
Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia	16
Inhibition of PDIA3 in club cells attenuates osteopontin production and lung fibrosis	16
Muscle memory: genetic factors underlying functional impairment in COPD	16
Effect modification of greenness on PM2.5associated all-cause mortality in a multidrug-resistant tuberculosis cohort	16
Effects of enhanced recovery after surgery plus pulmonary rehabilitation on complications after video-assisted lung cancer surgery: a multicentre randomised controlled trial	16
Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study	16
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	16
Risk of hypersensitivity pneumonitis and other interstitial lung diseases following organic dust exposure	16
Untargeted Molecular Analysis of Exhaled Breath as a Diagnostic Test for Ventilator-Associated Lower Respiratory Tract Infections (BreathDx)	16
British Thoracic Society Guideline for pleural disease	16
Impact of lung function on cardiovascular diseases and cardiovascular risk factors: a two sample bidirectional Mendelian randomisation study	16
Cause or consequence in idiopathic pulmonary fibrosis: using genetic data to back the right horse	16
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening	15
Long-term exposure to low-level crystalline silica and risk assessment of silicosis: a cohort study	15
Journal club	15
Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma	15
Targeting daytime normocapnia with nocturnal NIV in chronic hypercapnic COPD: the new paradigm?	15
Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study	14
Journal club	14
Haemoptysis with a Danish connection	14
Disease monitoring using lung function trajectory in lymphangioleiomyomatosis: assessment in two national cohorts	14
A rare cause of an 18F-FDG positron emission tomography-positive lung lesion: look for what was lost…	14
A rare condition masquerading as lung cancer	14
Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm3minimum size threshold for multidisciplinary team referral	14
Highlights from this issue	14
Journal club	14
Journal club	14
Life’s Essential 8 and risks of mortality and cardiovascular morbidity in individuals with PRISm and its associations with transition trajectories of PRISm	13

Pulmonary rehabilitation: one size does not fit all	13
Childhood Interstitial Lung Disease (chILD): shining a new light on childhood!	13
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension	13
’Pulmonary tuberculosis presenting as massive spontaneous pneumomediastinum and subcutaneous emphysema’	13
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	13
Journal club	13
Outcomes from a national screening program for Ukrainian refugees at risk of drug resistant tuberculosis in Wales	13
Limited side effects of asthma treatment on growth and bone health in children	13
Highlights from this issue	13
Journal club	13
Journal club	13
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy	12
Correction:RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	12
Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters	12
Impact of post-COVID-19 condition on health status and activities of daily living: the PRIME post-COVID study	12
Correction:Night shift work is associated with an increased risk of asthma	12
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial	12
Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators	12
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients	12
Adult asthma hospitalisations decreased markedly in Finland and Sweden between 2006 and 2022	12
Optimising breathlessness triggered services for older people with advanced diseases: a multicentre economic study (OPTBreathe)	11
Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time?	11
Getting the best from pulmonary rehabilitation	11
Pneumothorax and antibiotic use: a clue to aetiology of primary spontaneous pneumothorax?	11
Mind the sleep: how does obstructive sleep apnoea syndrome relate to risk of dementia?	11
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	11
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort	11
Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care	11
Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis	11
Towards an integrated clinical network of care for children with sleep disordered breathing	11
Highlights from this issue	11
Platelet aggregates in lung capillaries in severely decompensated pulmonary hypertension	10
Prevalence of lung cysts in adolescents and adults with a germlineDICER1pathogenic/likely pathogenic variant: a report from the National Institutes of Health and International Pleuropulmonary B	10
Neutrophil responses to RSV infection show differences between infant and adult neutrophils	10
Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease	10
Opportunistic actinomycosis in pulmonary alveolar proteinosis	10
Integrative analyses for the identification of idiopathic pulmonary fibrosis-associated genes and shared loci with other diseases	10
Diffuse hyperdense micronodular airspace opacities in pulmonary alveolar microlithiasis	10
Guideline concordance for timely chest imaging after new presentations of dyspnoea or haemoptysis in primary care: a retrospective cohort study	10
Integrated disease management: good news but more work to do	10
Mucus clears from the trachea in a helix: a new twist to understanding airway diseases	10
Toxic metals and lung health: silent poisons?	10
Lower airway microbiota in COPD and healthy controls	10
Predicting the risk of pulmonary deterioration in sarcoidosis	10
Remote vision-based digital patient monitoring of pulse and respiratory rates in acute medical wards	10
‘Double-bifurcated’ stent: when 3D is not an option	10
Journal club	10
Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China	10
Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis	10
Immediate smoking cessation support during lung cancer screening: long-term outcomes from two randomised controlled trials	10
Consolidation with pseudocavitation	10
Community-based approaches to improve tuberculosis services: observations from preintervention and postintervention surveys in a high TB burden disadvantaged community in India	10
Integrated stop smoking interventions are essential to maximise the health benefits from lung cancer screening	10
Obstructive sleep apnoea syndrome and future risk of dementia among individuals managed in UK general practice	10
Comparative estimate of glucose-lowering therapies on risk of incident pneumonia and severe sepsis: an analysis of real-world cohort data	10
Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial	9
TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial	9
Lifetime lung function trajectories: insights into risk factors, consequences and implications	9
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study	9
Lifetime occupational exposures and chronic obstructive pulmonary disease risk in the UK Biobank cohort	9
Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant	9
Eosinophil granule proteins: what they can tell us about asthma	9
ABCA3-related interstitial lung disease beyond infancy	9
Non-invasive ventilation versus invasive weaning in critically ill adults: a systematic review and meta-analysis	9
COVID-19 hospital activity and in-hospital mortality during the first and second waves of the pandemic in England: an observational study	9
BTS clinical statement for the assessment and management of respiratory problems in athletic individuals	9
Artificial stone silicosis arrives in the UK: a tragic case of history repeating	9
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	9
Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction	9
A structural and metabolic framework for classifying pre-clinical tuberculosis infection phenotypes using 18F-FDG PET-CT: a prospective cohort analysis followingM. tuberculosisexposure	9
Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe	9